相似文献
1
SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection.
J Thorac Oncol. 2023 Jan;18(1):31-46. doi: 10.1016/j.jtho.2022.10.002. Epub 2022 Oct 12.
2
Identification of Small and Non-Small Cell Lung Cancer Markers in Peripheral Blood Using Cytokinesis-Blocked Micronucleus and Spectral Karyotyping Assays.
Cytogenet Genome Res. 2017;152(3):122-131. doi: 10.1159/000479809. Epub 2017 Sep 13.
3
When is surgery indicated for small-cell lung cancer?
Lung Cancer. 2015 Dec;90(3):582-9. doi: 10.1016/j.lungcan.2015.10.019. Epub 2015 Oct 17.
4
Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study.
Chest. 2020 Oct;158(4):1723-1733. doi: 10.1016/j.chest.2020.04.068. Epub 2020 May 26.
5
Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.
Chest. 2018 Dec;154(6):1284-1290. doi: 10.1016/j.chest.2018.07.029. Epub 2018 Aug 3.
6
Small cell lung cancer in the young: Characteristics, diagnosis and outcome data.
Clin Respir J. 2019 Feb;13(2):98-104. doi: 10.1111/crj.12986. Epub 2019 Jan 28.
7
Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
J Thorac Oncol. 2019 Mar;14(3):436-444. doi: 10.1016/j.jtho.2018.11.002. Epub 2018 Nov 13.
8
Changing epidemiology of elderly small cell lung cancer patients over the last 40 years; a SEER database analysis.
Clin Respir J. 2018 Mar;12(3):1093-1099. doi: 10.1111/crj.12632. Epub 2017 Apr 12.
9
Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer.
Proteomics Clin Appl. 2018 Nov;12(6):e1800015. doi: 10.1002/prca.201800015. Epub 2018 Jul 5.
10
Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Mol Med Rep. 2018 Aug;18(2):1538-1550. doi: 10.3892/mmr.2018.9095. Epub 2018 May 29.
引用本文的文献
1
Real-world evidence on the survival benefit of immune checkpoint inhibitors in combination with cytotoxic chemotherapy for patients with extensive-disease small-cell lung cancer: the Tokushukai Real World Data Project (TREAD) 06.
BMC Cancer. 2025 Aug 27;25(1):1379. doi: 10.1186/s12885-025-14701-z.
2
The relationship between hemoglobin, albumin, lymphocyte, and platelet score and mortality in non-small cell lung cancer.
Medicine (Baltimore). 2025 Aug 22;104(34):e43985. doi: 10.1097/MD.0000000000043985.
3
Agapanthussaponin A from the Underground Parts of Induces Apoptosis and Ferroptosis in Human Small-Cell Lung Cancer Cells.
Molecules. 2025 Jul 30;30(15):3189. doi: 10.3390/molecules30153189.
4
B7-H3 in Cancer Immunotherapy-Prospects and Challenges: A Review of the Literature.
Cells. 2025 Aug 6;14(15):1209. doi: 10.3390/cells14151209.
5
Demographic and racial disparities in small-cell lung carcinoma: trends in diagnosis to treatment time, chemoradiotherapy seeking, and incidence rates-A SEER database analysis (2000-2021) with Bayesian multilevel regression modeling.
Ann Med Surg (Lond). 2025 Jul 16;87(8):4785-4802. doi: 10.1097/MS9.0000000000003593. eCollection 2025 Aug.
6
Pre-treatment Circulating Tumor Cell Associated White Blood Cell Clusters Independently Predict Poor Survival in Patients with Extensive-disease Small Cell Lung Cancer.
Biomark Insights. 2025 Aug 9;20:11772719251338620. doi: 10.1177/11772719251338620. eCollection 2025.
7
P21 activated kinase 6: a promising tool for predicting small cell lung cancer diagnosis and treatment response.
PeerJ. 2025 Jul 21;13:e19714. doi: 10.7717/peerj.19714. eCollection 2025.
8
Mushroom Bioactive Molecules as Anticancerous Agents: An Overview.
Food Sci Nutr. 2025 Jul 14;13(7):e70580. doi: 10.1002/fsn3.70580. eCollection 2025 Jul.
9
Redefining the Fight Against SCLC: Standards, Innovations, and New Horizons.
Cancers (Basel). 2025 Jul 7;17(13):2256. doi: 10.3390/cancers17132256.
10
Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial - protocol for a phase II study.
BMJ Open. 2025 Jul 7;15(7):e101571. doi: 10.1136/bmjopen-2025-101571.
本文引用的文献
1
Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation.
Cancer Discov. 2023 Jul 7;13(7):1572-1591. doi: 10.1158/2159-8290.CD-22-0620.
2
Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial.
Lung Cancer. 2022 Sep;171:26-33. doi: 10.1016/j.lungcan.2022.07.007. Epub 2022 Jul 15.
3
Applying circulating tumor DNA methylation in the diagnosis of lung cancer.
Precis Clin Med. 2019 Mar;2(1):45-56. doi: 10.1093/pcmedi/pbz003. Epub 2019 Mar 15.
4
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13.
5
Electronic cigarette use among adults in 14 countries: A cross-sectional study.
EClinicalMedicine. 2022 Apr 21;47:101401. doi: 10.1016/j.eclinm.2022.101401. eCollection 2022 May.
6
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program.
Clin Cancer Res. 2022 Jun 1;28(11):2349-2360. doi: 10.1158/1078-0432.CCR-21-2861.
7
Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action.
Tob Control. 2022 Mar;31(2):129-137. doi: 10.1136/tobaccocontrol-2021-056535.
8
New genomic technologies for multi-cancer early detection: Rethinking the scope of cancer screening.
Cancer Cell. 2022 Feb 14;40(2):109-113. doi: 10.1016/j.ccell.2022.01.012. Epub 2022 Feb 3.
9
Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
Ann Oncol. 2022 Apr;33(4):395-405. doi: 10.1016/j.annonc.2022.01.008. Epub 2022 Jan 25.
10
Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality: A Global Analysis.
Chest. 2022 Apr;161(4):1101-1111. doi: 10.1016/j.chest.2021.12.655. Epub 2022 Jan 11.
Zotero 插件